Literature DB >> 18056444

Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.

Fuminori Katou1, Haruo Ohtani, Yoshiko Watanabe, Takashi Nakayama, Osamu Yoshie, Kenji Hashimoto.   

Abstract

The significance of tumor-infiltrating lymphocytes (TIL) has attracted much attention in relation to the prognosis of patients. We herein examined the activation status of the TILs in relation to the tumor microenvironment. By using frozen sections of human early-stage tongue cancers (n = 22), the TILs in the cancer nests and those in the cancer stroma were compared for the expression of PD-1, NKG2A, NKG2D, CD69, and Ki-67. The lymphocytes in oral lichen planus, an active immune response-mediated mucosal disease, were also analyzed for comparison purposes. All of the cancer specimens were abundantly infiltrated by CD8(+) T cells and CD56(+) natural killer (NK) cells in the stroma, as well as in the tumor nest. The tumor nest-infiltrating (intraepithelial) CD8(+) T cells frequently expressed PD-1, an inhibitory receptor, in sharp contrast to those in the stroma or in the lichen planus. Conversely, the intraepithelial CD8(+) T cells only infrequently expressed NKG2D, an activating receptor, in contrast to those in the stroma or in the lichen planus. No intraepithelial CD8(+) T cells expressed Ki-67, a proliferation-associated marker, whereas those in the stroma frequently expressed it. Furthermore, the intraepithelial NK cells expressed NKG2A, an inhibitory receptor, more frequently than those in the stroma or the lichen planus. Collectively, the intraepithelial CD8(+) T cells and NK cells are phenotypically inactivated, whereas stromal counterparts are phenotypically just as active as those in the lichen planus. These results suggest the first-step occurrence of an immune evasion mechanism in the tumor nest of oral squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056444     DOI: 10.1158/0008-5472.CAN-07-2637

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Low-risk population among patients with tumor-node-metastasis stage III/IV oral squamous cell carcinoma.

Authors:  Tohru Ikeda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Yuu Ozaki-Honda; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

3.  Lymphocytic host response to oral squamous cell carcinoma: an adaptive T-cell response at the tumor interface.

Authors:  Sara Maleki; Nicolas F Schlecht; Christian Keller; Janice Diaz; Jason Moss; Michael B Prystowsky; Fernando Macian; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2011-02-12

Review 4.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

Review 5.  Extravillous trophoblast and decidual natural killer cells: a remodelling partnership.

Authors:  Alison E Wallace; Rupsha Fraser; Judith E Cartwright
Journal:  Hum Reprod Update       Date:  2012-04-20       Impact factor: 15.610

6.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

7.  PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients.

Authors:  Fernando Concha-Benavente; Benjamin Kansy; Jessica Moskovitz; Jennifer Moy; Uma Chandran; Robert L Ferris
Journal:  Cancer Immunol Res       Date:  2018-10-03       Impact factor: 11.151

8.  Innate immune reactions in locally limited tonsillar cancer.

Authors:  Yuichiro Kuratomi; Kenichiro Kusano; Rintaro Shimazu; Akira Inokuchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-08       Impact factor: 2.503

Review 9.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 10.  Tumor immune microenvironment in head and neck cancers.

Authors:  Samantha M Y Chen; Alexandra L Krinsky; Rachel A Woolaver; Xiaoguang Wang; Zhangguo Chen; Jing H Wang
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.